Subcutaneous route of natalizumab administration for relapsing multiple sclerosis patients
Multiple sclerosis (MS) is an autoimmune, demyelinating and neurodegenerative disease of the central nervous system (CNS) leading to increasing disability over time and reduced health-related quality...